Citation Impact

Citing Papers

A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy‐induced febrile neutropenia in children
2012
Dual-purpose isocyanides produced by Aspergillus fumigatus contribute to cellular copper sufficiency and exhibit antimicrobial activity
2021
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Fosfomycin: an old, new friend?
2009
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
2013 Standout
Executive Summary: IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults
2012
The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis
2005
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis
2007
Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role?
2014
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Cystic Fibrosis Pulmonary Guidelines
2009
Acute kidney injury
2012 Standout
Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia
2013
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
2009
Nitric oxide synthases: regulation and function
2011 Standout
FLUID RESUSCITATION IN SEVERE SEPSIS AND SEPTIC SHOCK
2007
Cystic fibrosis
2016 Standout
The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations
2017
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial
2014
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
2009
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
A global survey of potential acceptance of a COVID-19 vaccine
2020 Standout
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Severe Sepsis and Septic Shock
2013 Standout
Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
2008
The Science of Antibiotic Discovery
2020 Standout
Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care*
2009
Extended-spectrum β-lactamase-producing organisms
2009
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
2014
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
2015 Standout
Sepsis and septic shock
2018 Standout
The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects*
2006
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
2010
Canadian clinical practice guidelines for acute and chronic rhinosinusitis
2011
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment
2012
Prevention of Venous Thromboembolism
2004 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*
2015
Epidemiology of severe sepsis
2013
Validation of Predictors of Adverse Outcomes in Hospital-Acquired Pneumonia in the ICU*
2013
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
2006
Tackling antibiotic resistance: the environmental framework
2015 Standout
Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta‐analysis of randomized trials
2008
Airway Mucus Function and Dysfunction
2010 Standout
Uncomplicated Urinary Tract Infection
2012 Standout
Emerging drugs for the treatment of sepsis
2016
Galactomannan in Bronchoalveolar Lavage Fluid
2007
Epidemiology of Invasive Mold Infections in Lung Transplant Recipients
2014
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
2009 Standout
Immunity to fungal infections
2011 Standout
Macroscopic Postmortem Findings in 235 Surgical Intensive Care Patients with Sepsis
2009
Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis
2018
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Role of nitric oxide in shock: the large animal perspective
2009
IL-22 defines a novel immune pathway of antifungal resistance
2010
Mathematical Modeling of Bacterial Kinetics to Predict the Impact of Antibiotic Colonic Exposure and Treatment Duration on the Amount of Resistant Enterobacteria Excreted
2014
Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis
2011
The human microbiome: at the interface of health and disease
2012 Standout
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Invasive Aspergillosis in Critically Ill Patients without Malignancy
2004
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
2021
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
2015
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study
2011
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults
2012
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
2016
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Invasive Candidiasis
2015 Standout
High-Throughput Synthesis of Single-Layer MoS2 Nanosheets as a Near-Infrared Photothermal-Triggered Drug Delivery for Effective Cancer Therapy
2014
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Antibiotics for clinically diagnosed acute rhinosinusitis in adults
2012
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
2014
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies
2009
Deep vein thrombosis: prophylaxis in acute spinal cord injured patients.
1988
Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia
2014
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013
2016
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
2011
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
2008
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout

Works of George Dimοpoulos being referenced

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]
2005
DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic
2012
Impact of patient position on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials
2009
Ventilator-Associated Pneumonia
2008
Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis
2008
Fluoroquinolones compared with  -lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials
2008
Chemotherapy-induced neutropenia in lung cancer patients: The role of antibiotic prophylaxis
2011
Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
2013
Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors
2013
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
2010
Community-acquired Stenotrophomonas maltophilia infections: a systematic review
2009
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia
2013
Potential risk factors for infection with Candida spp. in critically ill patients
2004
Disseminated Aspergillosis in Intensive Care Unit Patients: An Autopsy Study
2003
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
2009
What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review
2013
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
2015
Prevalence, Risk Factors, and Mortality for Ventilator-Associated Pneumonia in Middle-Aged, Old, and Very Old Critically Ill Patients*
2013
Post mortem examination in the intensive care unit: still useful?
2004
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
2012
H1N1v influenza vaccine in Greek medical students
2010
Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials
2008
Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin
2008
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
2015
Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia
2008
Early Switch to Oral Treatment in Patients with Moderate to Severe Community-Acquired Pneumonia
2008
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
2012
Low-Dose Vasopressin in the Treatment of Septic Shock in Sheep
2003
Optimal Adrenergic Support in Septic Shock Due to Peritonitis
2003
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis
2007
Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus
2020
Are infections due to resistant pathogens associated with a worse outcome in critically ill patients?
2003
Attributable Mortality of Stenotrophomonas Maltophilia Infections: A Systematic Review of the Literature
2009
Rankless by CCL
2026